Da Hee Han, PharmD, Author at Clinical Pain Advisor

Acute Pain

A Popular Holiday Gift May End Up Being Safety Hazard

By

Da Hee Han, PharmD

December 31, 2015

The CPSC has issued a safety statement regarding the new must-have product of the season: hoverboards.

Regulatory Issues

FDA Safety Alert for Diabetes Drug Class

By

Da Hee Han, PharmD

December 4, 2015

A safety review conducted by the Food and Drug Administration (FDA) has led to new warnings added to the prescribing information for sodium-glucose co-transporter 2 (SGLT2) inhibitors used to treat type 2 diabetes.

Treatments

New Opioid Alternative Promising for Anesthesia, Sedation

By

Da Hee Han, PharmD

November 23, 2015

Isovaline may be a new alternative to opioids for anesthesia and procedural sedation, new data published in Anesthesia & Analgesia has shown.

First App Launched to Identify Drug Shortages

Treatments

FDA Issues Severe, Persistent Joint Pain Warning For Diabetes Drug Class

By

Da Hee Han, PharmD

August 31, 2015

The Food and Drug Administration (FDA) is warning that use of dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain which could be severe and disabling.

Working over 55 hours per week correlates with increased risk of coronary heart disease and stroke.

Migraine & Headache

Report: TENS Device Highly Effective For Migraine Relief

By

Da Hee Han, PharmD

August 26, 2015

Cefaly transcutaneous electrical nerve stimulation (TENS) device provided relief to 81 percent of migraine sufferers who used it, according to results of a clinical study published in The Journal of Headache and Pain.